NASDAQ:LTRN

Lantern Pharma Stock Predictions

Healthcare > Biotechnology

Buy LTRN

*Your capital is at risk

$3.40

-0.340 (-9.09%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

LTRN Prediction Chart

LTRN Predictions History

Latest community submissions for LTRN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Warren Pro	Feb 18, 2025	$5.14 +2.52%	$4.55	X	87.11%	0
tjweathers0	Feb 18, 2025	Bullish	$4.55	X	—	0
PredictionBot.Warren Pro	Feb 10, 2025	$4.90 -3.32%	$5.05	V	97.06%	0
PredictionBot.Kathy Pro	May 2, 2024	$5.08 -5.72%	$5.49	X	92.56%	0
PredictionBot.Warren Pro	May 2, 2024	$5.58 +3.58%	$5.49	V	98.31%	1
15mvogt	May 2, 2024	Bullish	$5.49	V	—	1
sander7100 yo bro Pro @sander7100yobro.167552	Sep 14, 2020	$13.92 -25.56%	$18.70	X	74.44%	1
JS Pro	Sep 14, 2020	$18.39 -1.66%	$18.70	X	98.34%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LTRN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT LANTERN PHARMA INC.

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by